GDNF and Parkinson disease: Neurotrophic factors, such as BDNF and GDNF, are well-known regulators of the dopamine system and are described as candidates for treating Parkinson’s disease as they exhibit dual neuroprotective and neurogenic properties (Lindholm and Saarma, 2021).